FindTrial
Sign In

Depression and hepatocellular carcinoma risk

Depression and hepatocellular carcinoma risk

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016674
Enrollment
Unknown
Registered
2018-06-15
Start date
2018-06-15
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Case series:Nil

Sponsors

The First Hospital, Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Aged =18 year; no history of previous anticancer therapy; no history of other malignancies.

Exclusion criteria

Exclusion criteria: Tumors of uncertain origin; probable metastatic liver tumor; received any psychotropic medications, such as antidepressants, antipsychotics, mood stabilizers, narcotics and benzodiazepines, or any other anti-depressive therapies during the study period.

Design outcomes

Primary

MeasureTime frame
HAMD-17;BAI;SSRS;cortisol;relapse;cytokines;—

Contacts

Public ContactLi Chen

School of Nursing, Jilin University

381167771@qq.com+86 13194316883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026